	All Together Now: Standardization of Nomenclature for Neuroendocrine Neoplasms across Multiple Organs. Clin Lab Med Jafari P, Husain AN, Setia N. PMID: 42526975 [PubMed - indexed for MEDLINE]
	Maximal Ablative Irradiation Because of Encasement for Patients With Locally Advanced Pancreatic Cancer: A Nonrandomized Clinical Trial. JAMA Surg Reyngold M, Wei AC, O'Reilly EM, D'Angelica MI, Kingham TP, Soares KC, Varghese AM, White C, Zinovoy M, Romesser PB, Wu A, Hajj C, Cuaron JJ, Khalil DN, Balogun F, Park W, Yu KH, Balachandran VP, Drebin JA, Lagratta M, Zhang Z, Jarnagin WR, Crane CH. PMID: 42525419 [PubMed - as supplied by publisher]
	Fatty acids metabolic reprogramming and tumor microenvironment in pancreatic cancer: targeting pathways. Clin Exp Med Ehab B, Saleh E. PMID: 42525264 [PubMed - indexed for MEDLINE]
	Definition of Conversion Therapy and Neoadjuvant Therapy for Hepatocellular Carcinoma: A Consensus Guideline from the Japan Liver Cancer Association. Liver Cancer Ichida A, Tateishi R, Hatano E, Taketomi A, Tanabe M, Nouso K, Minami Y, Murakami T, Shimada M, Hasegawa K. PMID: 42524660 [PubMed - as supplied by publisher]
	Systemic therapy for gastroenteropancreatic neuroendocrine neoplasms: current landscape and future directions. Ther Adv Med Oncol So E, Morizane C, Okusaka T. PMID: 42524036 [PubMed]
	Combination therapy with anti-PD-1 antibody, radiotherapy, and tyrosine kinase inhibitor for unresectable primary ectopic hepatocellular carcinoma: a case report with genomic profiling and literature review. Front Immunol Tang P, Liu W, Xu Y, Long Y, Li Y, Li J, Liao M, Wang X, Zhou J, Zeng Y. PMID: 42523995 [PubMed - indexed for MEDLINE]
	Cancer outcomes and biological mechanisms among patients with type 2 diabetes mellitus using glucagon-like peptide-1 receptor agonists: a systematic review and meta-analysis. Front Oncol Eze ED, Ntakirutimana L, Terkimbi SD, Walle M, Umar AH, Wondimu DH, Olubiyi MV, Okeke OC, Onaadepo O, Abdulazeez J, Ikwuka DC, Ani EJ, Alagbonsi AI. PMID: 42523690 [PubMed]
	Metabolic comorbidities affect the survival of hepatitis B virus-related hepatocellular carcinoma in Chinese patients: a retrospective cohort study with propensity score matching. Front Oncol Zhou Z, Zheng X, Lin Z, Chen X, Xie M. PMID: 42523603 [PubMed]
	Red and processed meat consumption and the risk of pancreatic cancer: a systematic review and dose-response meta-analysis. Front Nutr Lu Y, Gu M, Zhao Y, Ma L, Wei Y, Liu Z, Wu Y, Fu X, Liang J, Yang L, Su Y, Chen T, Zhang D, Hu F, Hu D, Zhang M. PMID: 42523589 [PubMed]
	Prognostic and Predictive Values of Transcriptomic Signatures in Metastatic Pancreatic Cancer: A Biomarker Analysis of Three French Multicenter Prospective Randomized Controlled Phase 2 Trials (Prodige35, Prodige37 and AFUGEM). Cancer Lett Zhao S, Nicolle R, Taieb J, Dahan L, Abdallah R, Bouché O, Desrame J, Phelip JM, Evesque L, Akouz FK, de Mestier L, Trouilloud I, Malka D, Shen B, Cros J, Laurent-Puig P, Bachet JB. PMID: 42521075 [PubMed - as supplied by publisher]
	Discovery of a prognostic two-lncRNA panel correlated with immune-associated transcripts for forecasting overall survival in pancreatic cancer. Immunobiology Eftekhari H, Safarzadeh A, Babakhanzadeh E, Ghafouri-Fard S. PMID: 42520353 [PubMed - as supplied by publisher]
	Correction: Impact of Hypertrophy-Oriented Resistance Training on Muscle Mass and Quality of Life in Patients with Unresectable Pancreatic Cancer (HY-PANC): Study Protocol for a Randomized Controlled Trial. Curr Protoc Braceras Arias P, Burgos Postigo S, B Alejo L. PMID: 42519871 [PubMed - in process]
	Research advances on tumor-associated macrophages in pancreatic cancer. Biochem Biophys Rep Miao JY, Zhang LQ, He Y, Wang W. PMID: 42519576 [PubMed]
	Dual-Modality SPECT and Viscosity-Responsive AIE Fluorescence Probe for Pancreatic Cancer Diagnosis and Intraoperative Guidance. ACS Omega Zhang K, Chen Q, Huang Q, Qi X, Qin Y, Wang D, Zhu R, Wang G, Ma X. PMID: 42518470 [PubMed]
	Berberine-induced ferroptosis as a novel anti-cancer strategy: Molecular, epigenetic and translational perspectives. EXCLI J Agrawal N, Gupta G, Pandey SN, Rekha A, Vijayan MP, Chellappan DK, Raj Paudal K, Singh SK, Dua K. PMID: 42517086 [PubMed]
	Molecular Imaging in Pancreatic Cancer: Current Applications and Future Perspectives. Pharmaceuticals (Basel) Liu Y, Lan K, Sun Z, Huang W. PMID: 42515759 [PubMed]
	Study on Synergistic Treatment of Pancreatic Cancer by Multiple Small Interfering Ribonucleic Acid Lipid Nanoparticles of Disk Domain Receptor 1, Transforming Growth Factor Î²1, Tumor-Associated Calcium Signal Transduction Protein 2, and Polyligand Proteoglycan 1. Pharmaceutics Wang R, Zeng Y, Zeng Z, Xie T. PMID: 42514856 [PubMed]
	Estimation of Resting Energy Expenditure in Patients Undergoing Total or Partial Pancreatectomy for Pancreatic Tumors. Nutrients Papanastasiou P, Bouloubasi Z, Karayiannis D, Georgolopoulou O, Chasiotis D, Goulis I, Dimitriou M. PMID: 42514285 [PubMed - indexed for MEDLINE]
	Precision Therapeutics in Pancreatic Cancer: Emerging Targeted, Immune, and Antibody-Drug Conjugate Strategies Exemplified by Adagrasib, Dostarlimab, and Trastuzumab Deruxtecan. J Clin Med Kawczak P, Kawczak K, B. PMID: 42513436 [PubMed]
	Endoscopic Ultrasound-Guided Radiofrequency Ablation (EUS-RFA): Are We Getting Evidence-Based Results? A Systematic Review According to the Levels of Evidence. Medicina (Kaunas) Lisotti A, Masciangelo G, Tacelli M, Crinò SF, Pham KD, Khoury T, Fusaroli P, Napoléon B. PMID: 42512924 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 61034

Page 1 of 3052



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy